These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7519690)

  • 1. Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system.
    Landsberg L
    J Cardiovasc Pharmacol; 1994; 23 Suppl 1():S1-8. PubMed ID: 7519690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and the sympathetic nervous system in the pathophysiology of hypertension.
    Landsberg L
    Blood Press Suppl; 1996; 1():25-9. PubMed ID: 9162434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity.
    Gilardini L; Parati G; Sartorio A; Mazzilli G; Pontiggia B; Invitti C
    J Hum Hypertens; 2008 Feb; 22(2):75-82. PubMed ID: 17882228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
    Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and hypertension: experimental data.
    Landsberg L
    J Hypertens Suppl; 1992 Dec; 10(7):S195-201. PubMed ID: 1291654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, hyperinsulinemia and hypertension.
    Weidmann P; de Courten M; Böhlen L
    J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men.
    Ljung T; Holm G; Friberg P; Andersson B; Bengtsson BA; Svensson J; Dallman M; McEwen B; Björntorp P
    Obes Res; 2000 Oct; 8(7):487-95. PubMed ID: 11068954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular vagosympathetic activity in rats with ventromedial hypothalamic obesity.
    Valensi P; Doaré L; Perret G; Germack R; Pariès J; Mesangeau D
    Obes Res; 2003 Jan; 11(1):54-64. PubMed ID: 12529486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between vasosympathetic activity and insulin resistance in normotensive and mildly hypertensive obese patients].
    Valensi P; Dabire H; Brahimi M; Paries J; Platon P; Attali JR
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):941-3. PubMed ID: 11575236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac autonomic nervous system activity in obesity.
    Liatis S; Tentolouris N; Katsilambros N
    Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():476-83. PubMed ID: 16444178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome.
    Landsberg L
    Ann N Y Acad Sci; 1999 Nov; 892():84-90. PubMed ID: 10842654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, blood pressure, and the sympathetic nervous system.
    Landsberg L; Troisi R; Parker D; Young JB; Weiss ST
    Ann Epidemiol; 1991 May; 1(4):295-303. PubMed ID: 1669511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance.
    de Jongh RT; Serné EH; IJzerman RG; de Vries G; Stehouwer CD
    Circulation; 2004 Jun; 109(21):2529-35. PubMed ID: 15136505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
    Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch
    Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and etiology of essential hypertension: role of dietary carbohydrate.
    Kopp W
    Med Hypotheses; 2005; 64(4):782-7. PubMed ID: 15694697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of obesity-induced hypertension.
    Kotsis V; Stabouli S; Papakatsika S; Rizos Z; Parati G
    Hypertens Res; 2010 May; 33(5):386-93. PubMed ID: 20442753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, metabolism, and hypertension.
    Landsberg L
    Yale J Biol Med; 1989; 62(5):511-9. PubMed ID: 2697985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects.
    Arauz-Pacheco C; Lender D; Snell PG; Huet B; Ramirez LC; Breen L; Mora P; Raskin P
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1172-8. PubMed ID: 8972887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.